EyePoint Pharmaceuticals
EYPT
EYPT
35 hedge funds and large institutions have $5.22M invested in EyePoint Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
64% less call options, than puts
Call options by funds: $10K | Put options by funds: $28K
Holders
35
Holding in Top 10
–
Calls
$10K
Puts
$28K
Top Buyers
| 1 | +$481K | |
| 2 | +$173K | |
| 3 | +$111K | |
| 4 |
Renaissance Technologies
New York
|
+$64.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$59.6K |
Top Sellers
| 1 | -$238K | |
| 2 | -$57K | |
| 3 | -$52K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$40K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$37K |